» Articles » PMID: 18056822

Diagnostic Criteria Influence Dementia Prevalence

Overview
Publisher Elsevier
Specialty Geriatrics
Date 2007 Dec 7
PMID 18056822
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The objective of this study was to compare the prevalence of dementia using different diagnostic systems, and to investigate the influence of the different diagnostic components (memory impairment, personality changes, definition of other intellectual functions) on the prevalence.

Methods: A general population sample of 1,019 elderly living in Gothenburg, Sweden was investigated by using the Comprehensive Psychopathological Rating Scale as well as specific assessments relevant for dementia diagnoses. Diagnoses were given according to the 9th and 10th version of the International Classification of Diseases (ICD-9, ICD-10) as well as the 3rd revised and 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R, DSM-IV). Further, "historical" criteria for dementia were applied as had been used in older studies.

Results: DSM-IV dementia occurred most frequently (9.6%), followed by dementia according to "historical" criteria (7.4%), DSM-III-R (6.3%), ICD-10 (3.1%), and ICD-9 (1.2%). The kappa values for the agreement between the diagnostic systems were between 0.166 and 0.810. The requirement of both long-term and short-term memory impairment in DSM-III-R and personality changes in ICD-10 explained most of the differences. When these requirements were held constant, DSM-III-R, DSM-IV, ICD-10 and "historical" criteria identified predominantly the same persons as demented (kappa: 0.810-1.000).

Conclusion: Prevalence of dementia varied widely depending on diagnostic classification system used. For DSM-III-R, DSM-IV, ICD-10, and "historical" criteria, the definitions of personality changes and combinations of memory impairment lead to differing prevalence rates, whereas the definitions of other intellectual functions have little impact.

Citing Articles

Toward an intelligent computing system for the early diagnosis of Alzheimer's disease based on the modular hybrid growing neural gas.

Cabrera-Leon Y, Fernandez-Lopez P, Garcia Baez P, Kluwak K, Navarro-Mesa J, Suarez-Araujo C Digit Health. 2024; 10:20552076241284349.

PMID: 39381826 PMC: 11459500. DOI: 10.1177/20552076241284349.


Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study.

Arvidsson Radestig M, Skoog J, Zetterberg H, Skillback T, Zettergren A, Rydberg Sterner T J Alzheimers Dis. 2023; 91(1):291-303.

PMID: 36617786 PMC: 9881027. DOI: 10.3233/JAD-220452.


A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes.

Bellomo G, Piscopo P, Corbo M, Pupillo E, Stipa G, Beghi E Neurol Sci. 2022; 43(12):6667-6691.

PMID: 35976476 PMC: 9663371. DOI: 10.1007/s10072-022-06319-x.


Changes in the use of psychotropic drugs during the course of Alzheimer's disease: A large-scale longitudinal study of French medical records.

Ansart M, Epelbaum S, Houot M, Nedelec T, Lekens B, Gantzer L Alzheimers Dement (N Y). 2021; 7(1):e12210.

PMID: 34541292 PMC: 8439142. DOI: 10.1002/trc2.12210.


Decline in the Incidence of All-Cause and Alzheimer's Disease Dementia: a 12-Year-Later Rural Cohort Study in Korea.

Park J, Kim B, Kim K, Hahm B, Sohn J, Suk H J Korean Med Sci. 2019; 34(44):e293.

PMID: 31726496 PMC: 6856301. DOI: 10.3346/jkms.2019.34.e293.